Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MEPROBAMATE vs MESNA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MEPROBAMATE vs MESNA: Safety Overview

Metric MEPROBAMATE MESNA
Total FAERS Reports 427 4,892
Deaths Reported 320 1,029
Death Rate 74.9% 21.0%
Hospitalizations 55 2,155
Average Patient Age 44.8 yrs 39.3 yrs
% Female Patients 54.6% 46.8%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 13, 2010
Manufacturer Cipla USA Inc. Hikma Pharmaceuticals USA Inc.
Route ORAL INTRAVENOUS
Marketing Status Discontinued Prescription